“It has been a lot of interest this year in news models of care”, as well in “broader issues in drug user health”, says Jeffrey Lazarus, INHSU 2018 co-convenor. “We are getting beyond just looking at hepatitis C in people who inject drugs, and are including broader issues about improving health and well-being”, adds the specialist in an interview to News Farma.
Try to come-up with a comprehensive framework that helps to understand why certain people, particularly people who inject drugs, have difficulty accessing to DAA therapy was the main goal of the Stine Høj’s presentation. In an interview to News Farma, the specialist from Centre de Recherche of the Centre hospitalier de l'Université de Montréal (CHUM) says that this framework “allows us to find a way to intervein and to evaluate the program so we use to try improve treatment optic”.
During the session “Strategies to Facilitate Linkage to Care for PWID in Low and Middle Income Countries”, Shruti Mehta, professor on Johns Hopkins University, gives prominence to the monitoring process. In her belief, “if we don’t know where we start, we don’t know how to guide our programs and we won’t be able to measure the impact”.
As the main goal, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) wants to “provide evidence for better decisions and for action, for policy makers and for practitioners”. In an interview for News Farma, Alexis Goosdeel presents the major focus of action for the organization, based in Lisbon since 1994.